This article was automatically translated from HIBAPRESS, the Arabic version:
Hibapress
The Minister of Health and Social Protection, Amine Tahraoui, announced the launch of an in -depth revision process of the drug pricing system in Morocco.
This declaration was made Monday during the session of oral questions in the House of Representatives, in response to a question of the Haraki group on the national medication policy.
This ambitious reform aims to reconcile several major objectives: to improve the accessibility of citizens to drugs, in particular the most innovative, to preserve their purchasing power and ensure the viability of the health coverage system. The Minister stressed that a new pricing model is currently being developed in a consultation framework involving all stakeholders.
This model will be based on international standards while taking into account national specificities, with the ambition of establishing just, transparent and fair pricing. “Drug policy is one of the pillars of the reform of the national health system, as carried under the leadership of King Mohammed VI,” said Tahraoui.
Among the levers of this policy is the creation of the Moroccan Agency for Medicines and Health Products (AMMPs), now officially operational since the appointment of its director general last October, followed by the holding of its first board of directors.
The Minister highlighted the central role of this agency in the reorganization of the national pharmaceutical sector. It is notably responsible for improving the marketing authorization procedures, strengthening controls, the involvement of public and private actors, as well as the development of pharmaceutical sovereignty and national industrial innovation.
